Clinical Trial Update: Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating intracameral dexamethasone after cataract surgery in diabetics was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Endothelial Cell Loss
• Diabetes Mellitus

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Cairo University | Conditions: Diabetes Mellitus, Corneal Endothelial Cell Loss | Phase 4 | Status: WITHDRAWN